摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pyrido[3,4-c]pyridazin-4(1H)-one | 1312933-06-4

中文名称
——
中文别名
——
英文名称
pyrido[3,4-c]pyridazin-4(1H)-one
英文别名
1H-pyrido[3,4-c]pyridazin-4-one
pyrido[3,4-c]pyridazin-4(1H)-one化学式
CAS
1312933-06-4
化学式
C7H5N3O
mdl
——
分子量
147.136
InChiKey
LAOHRVYGGXOZEY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    3-硝基吡啶-4-羧酸盐酸 、 sodium dithionite 、 乙醇 、 sodium nitrite 作用下, 以 乙醇 为溶剂, 反应 7.33h, 生成 pyrido[3,4-c]pyridazin-4(1H)-one
    参考文献:
    名称:
    7‐Azacinnolin‐4(1H)‐1互变异构的制备和NMR研究
    摘要:
    作为我们目前对硝基吡啶研究的一部分,我们在此报告通过C-偶氮偶合制备新的环状杂环的方法。因此,通过重氮化从4-乙酰基-3-氨基吡啶制备了氮杂多酚,吡啶并[3,4-c]哒嗪-4(1 H)-one(38%)。1 H,13 C和15 N NMR光谱研究表明,氮杂肉桂碱仅以NH-酮互变异构形式存在,DMSO- d 6,CD 3 OD和D 2 O. J. Heterocyclic Chem。,(2011)。
    DOI:
    10.1002/jhet.580
点击查看最新优质反应信息

文献信息

  • 7-Azacinnolin-4(1H)-one preparation and NMR studies of tautomery
    作者:Vegar Stockmann、Sebastian Primpke、Anne Fiksdahl
    DOI:10.1002/jhet.580
    日期:2011.5
    As part of our current investigations of nitropyridines, we hereby report the preparation of a new annulated heterocycle by C‐azo coupling. Thus, the azacinnoline, pyrido[3,4‐c]pyridazin‐4(1H)‐one (38%), was prepared from 4‐acetyl‐3‐aminopyridine via diazotization. 1H, 13C, and 15N NMR spectroscopic investigations revealed that the azacinnoline exclusively exists in the NH‐keto tautomeric form in DMSO‐d6
    作为我们目前对硝基吡啶研究的一部分,我们在此报告通过C-偶氮偶合制备新的环状杂环的方法。因此,通过重氮化从4-乙酰基-3-氨基吡啶制备了氮杂多酚,吡啶并[3,4-c]哒嗪-4(1 H)-one(38%)。1 H,13 C和15 N NMR光谱研究表明,氮杂肉桂碱仅以NH-酮互变异构形式存在,DMSO- d 6,CD 3 OD和D 2 O. J. Heterocyclic Chem。,(2011)。
查看更多

同类化合物

2-(4-chlorophenyl)-7-(4-methylphenyl)-6,8-dioxo-3-thienyl-2,6,7,8-tetrahydropyrido[3,4-c]pyridazine-5-carbonitrile pyrido[4,3-e]furano[2,3-c]pyridazine 2,3,7,8-tetrahydro-7-amino-3,8-dioxo-2-p-tolylpyrido[3,4-c]pyridazine-4-carbonitrile 2,3,7,8-tetrahydro-3,8-dioxo-2-p-tolylpyrido[3,4-c]pyridazine-4-carbonitrile pyrido[3,4-c]pyridazin-4(1H)-one Pyrido<3,4-c>pyridazin 3,8-dioxo-2-phenyl-7H-pyrido[3,4-c]pyridazine-4-carbonitrile 8-bromopyrido[3,4-c]pyridazine-5-carboxylic acid 2-(4-chlorophenyl)-6-(furan-2-yl)-7-[(E)-furan-2-ylmethylideneamino]-3,8-dioxopyrido[3,4-c]pyridazine-4-carbonitrile 2-(4-chlorophenyl)-6-(furan-2-yl)-7-[(Z)-furan-2-ylmethylideneamino]-3,8-dioxopyrido[3,4-c]pyridazine-4-carbonitrile 2-(4-Chlorophenyl)-6-(furan-2-yl)-7-(furan-2-ylmethylideneamino)-3,8-dioxopyrido[3,4-c]pyridazine-4-carbonitrile 4-[(4-chlorophenyl)methyl]-2-[[(2R)-1-(2-ethylsulfonylethyl)pyrrolidin-2-yl]methyl]pyrido[3,4-c]pyridazin-1-ium 1-oxide 2,5,6,12-Tetrazatricyclo[7.4.0.02,6]trideca-1(9),4,7,10,12-pentaene tert-butyl N-[3-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]propyl]carbamate N-[2-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]ethyl]butanamide N-[(4-chlorophenyl)methyl]-6-(4-hydroxybut-2-ynyl)-4-oxo-1H-pyrido[3,4-c]pyridazine-3-carboxamide N-[3-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]propyl]-2-methylpropanamide N-[3-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]propyl]-2,2-dimethylpropanamide 3-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]propanoic acid N-[2-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]ethyl]-2,2-dimethylpropanamide N-[2-[(2R)-2-[[4-[(4-chlorophenyl)methyl]-1-hydroxypyrido[3,4-c]pyridazin-2-yl]methyl]pyrrolidin-1-yl]ethyl]-2-methylpropanamide 3,3,3-trifluoro-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)pyrrolidin-3-yl]propanamide N-cyclopropyl-1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidine-3-carboxamide Cyano-[3-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8,10,12-hexaen-13-yl)piperidin-1-yl]methanesulfinate 2-[3-(5,7,8,11-Tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8,10,12-hexaen-13-yl)piperidin-1-yl]sulfonylacetonitrile Cyano-[3-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8,10,12-hexaen-13-yl)piperidin-1-yl]methanesulfinic acid 2-cyano-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidin-3-yl]acetamide 1-(5,7,8,11-Tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)pyrrolidin-3-amine 3,3,3-trifluoro-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidin-3-yl]propanamide 1-(5,7,8,11-Tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidine-3-carboxylic acid 4,4,4-trifluoro-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidin-3-yl]butanamide 1-(5,7,8,11-Tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)piperidin-3-amine 2-cyano-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)pyrrolidin-3-yl]acetamide 1-(5,7,8,11-Tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)pyrrolidine-3-carboxylic acid 4,4,4-trifluoro-N-[1-(5,7,8,11-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7,9,11-hexaen-13-yl)pyrrolidin-3-yl]butanamide